Clinical Trial Update: Clinical Trial of High Dose CoQ10 in ALS [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating high-dose Coenzyme Q10 in amyotrophic lateral sclerosis, with results posted in Marc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Columbia University | Conditions: Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-03-17